National Research Corporation (NASDAQ:NRCIA) major shareholder K/I/E/Trust Under Agreement 3/ sold 9,000 shares of National Research Corporation stock in a transaction that occurred on Wednesday, November 1st. The stock was sold at an average price of $36.50, for a total value of $328,500.00. Following the transaction, the insider now owns 5,626,167 shares of the company’s stock, valued at $205,355,095.50. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

K/I/E/Trust Under Agreement 3/ also recently made the following trade(s):

  • On Monday, October 30th, K/I/E/Trust Under Agreement 3/ sold 500 shares of National Research Corporation stock. The stock was sold at an average price of $38.00, for a total value of $19,000.00.
  • On Friday, October 27th, K/I/E/Trust Under Agreement 3/ sold 13,821 shares of National Research Corporation stock. The stock was sold at an average price of $38.00, for a total value of $525,198.00.
  • On Wednesday, October 25th, K/I/E/Trust Under Agreement 3/ sold 2,127 shares of National Research Corporation stock. The stock was sold at an average price of $38.00, for a total value of $80,826.00.
  • On Monday, October 23rd, K/I/E/Trust Under Agreement 3/ sold 267 shares of National Research Corporation stock. The stock was sold at an average price of $38.00, for a total value of $10,146.00.
  • On Thursday, October 19th, K/I/E/Trust Under Agreement 3/ sold 109,000 shares of National Research Corporation stock. The stock was sold at an average price of $37.00, for a total value of $4,033,000.00.

Shares of National Research Corporation (NASDAQ:NRCIA) traded up $1.15 on Friday, reaching $37.45. The company’s stock had a trading volume of 19,086 shares, compared to its average volume of 40,930. The company has a market cap of $782.21 million, a price-to-earnings ratio of 46.11 and a beta of 1.70.

The firm also recently declared a quarterly dividend, which was paid on Friday, October 13th. Shareholders of record on Friday, September 29th were issued a $0.10 dividend. The ex-dividend date of this dividend was Thursday, September 28th. This represents a $0.40 annualized dividend and a yield of 1.07%. National Research Corporation’s dividend payout ratio (DPR) is presently 76.92%.

ILLEGAL ACTIVITY NOTICE: “National Research Corporation (NRCIA) Major Shareholder Sells $328,500.00 in Stock” was reported by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another website, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this story can be viewed at https://www.americanbankingnews.com/2017/11/03/national-research-corporation-nrcia-major-shareholder-sells-328500-00-in-stock.html.

Separately, Zacks Investment Research downgraded National Research Corporation from a “buy” rating to a “hold” rating in a report on Saturday, August 12th.

A number of institutional investors and hedge funds have recently modified their holdings of NRCIA. Citigroup Inc. raised its holdings in National Research Corporation by 120.2% in the 2nd quarter. Citigroup Inc. now owns 8,299 shares of the business services provider’s stock valued at $224,000 after acquiring an additional 4,531 shares during the last quarter. The Manufacturers Life Insurance Company raised its holdings in National Research Corporation by 252.1% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 9,090 shares of the business services provider’s stock valued at $244,000 after acquiring an additional 6,508 shares during the last quarter. Strs Ohio raised its holdings in National Research Corporation by 210.3% in the 2nd quarter. Strs Ohio now owns 12,100 shares of the business services provider’s stock valued at $325,000 after acquiring an additional 8,200 shares during the last quarter. Alliancebernstein L.P. raised its holdings in National Research Corporation by 5.1% in the 2nd quarter. Alliancebernstein L.P. now owns 12,369 shares of the business services provider’s stock valued at $333,000 after acquiring an additional 600 shares during the last quarter. Finally, Algert Global LLC acquired a new position in National Research Corporation in the 2nd quarter valued at $384,000. Institutional investors own 28.89% of the company’s stock.

National Research Corporation Company Profile

National Research Corporation, doing business as NRC Health, is a provider of analytics and insights for healthcare providers, payers and other healthcare organizations. The Company operates through six segments: Experience, The Governance Institute, Market Insights, Transparency, National Research Corporation Canada and Connect.

Receive News & Ratings for National Research Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research Corporation and related companies with MarketBeat.com's FREE daily email newsletter.